Capabilities

We can help to ensure your cell and gene therapies are safer, more effective, scalable, affordable and that they are successfully approved and reimbursed.

Our capabilities cover all aspects of ATMP development and commercialisation, from supporting researchers through to enabling patient access via the NHS.

Discover our Capabilities

Cell therapiesGene therapiesAutomationDigital innovationSupporting spin-outs, start-ups and sector investmentManufacturing innovationIntegrated non-clinical, regulatory and market access strategyFacilitating NHS adoption of ATMPsSkills and training

Find out more